-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Syros Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2024.
- Syros Pharmaceuticals, Inc. Return On Equity for the quarter ending March 31, 2024 was -409 %, a 333% decline year-over-year.
- Syros Pharmaceuticals, Inc. annual Return On Equity for 2023 was -283 %, a 162% decline from 2022.
- Syros Pharmaceuticals, Inc. annual Return On Equity for 2022 was -108 %, a 46.9% decline from 2021.
- Syros Pharmaceuticals, Inc. annual Return On Equity for 2021 was -73.5 %, a 39.8% increase from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)